Biotech Values

[oldberkeley]

>Several of us on the JAV board are asking the same question. It appears that value decline breeds the hope (desperate, IMO) of a juicy deal to reinflate shareholder value and allow a return of investment to above water and also be done with the risk in one fell swoop.<

Yes, the same discussion is occurring on the GTCB board. Hopefully our hope is not of the desperate variety, but you are exactly right about the motivation behind it: Who doesn't want shareholder value reinflated? Who doesn't want a return of investment to above water?